Cervical Cancer

1. Screening for Cervical Cancer, 1996
   
2. Guideline for Screening for Cervical Cancer
   
3. ICSI: Cervical cancer screening (Pap smears), Algorhitm, 2000 551 K, 20 pages
   
4. ISCI: Management of initial abnormal Pap smear, Algorithm, 2000 637 k, 31 pages
   
5. Counseling to Prevent Gynecologic Cancers
   
6. National Institutes of Health Consensus Development Statement - CERVICAL CANCER (1996)
   
7. New Zealand: Improving the National Cervical Screening Programme Law Changes to Support the Audit of the Programme, 2001 377 k, 18 pages
   
8. ACR Appropriateness Criteria™ for the role of imaging in cancer of the cervix, 1996-1999

See: Clinical Practice Guidelines < > Ginecology < > Oncology >> Cervical Cancer

1. Ovarian Cancer: Screening, Treatment, and Followup National Institutes of Health Consensus Development Conference Statement April 5-7, 1994
   
2. Screening for Ovarian Cancer, 1996
   
3. American College of Preventive Medicine: Screening Asymptomatic Women for Ovarian Cancer, 1966
4. Guidance on the Use of Taxanes for Ovarian Cancer, May 2000
   

See: Clinical Practice Guidelines < > Ginecology < > Oncology >> Ovarian Cancer

1. Guideline for Use of PSA and Screening for Prostate Cancer
   
2. Screening for Prostate Cancer, 1996
   
3. PART III: Screening for Prostate Cancer, Annals of Internal Medicine 1997;126:480-484
   
4. American College of Preventive Medicine: Screening For Prostate Cancer in American Men
5. Early Detection of Prostate Cancer Part I: Prior Probability and Effectiveness of Tests. Annals of Internal Medicine 1997;126:394-406
   
6. Early Detection of Prostate Cancer Part II: Estimating the Risks, Benefits, and Costs. Annals of Internal Medicine1997;126:468-479
   
7. American Urological Association: The management of clinically localized prostate cancer
8. American Cancer Society: Prostate Cancer Treatment Guidelines for Patients 724 KB, 52 pages
   
9. National Medical Research Council (Singapore): Prostate cancer (2000) 288 KB, 49 pages
   
10. Clinical Practice Guidelines for Prostate Cancer
11. Referral Guidelines for Suspected Urological Cancers
    
12. Clinical practice guidelines: reality bites. MJA 2000; 172: 287-291
    
13. Screening, case finding and evidence-based guidelines. MJA 1999; 171: 344-345
    
14. Cancer Care Ontario Practice Guidelines Initiative: Use of Strontium89 in Patients with Endocrine-Refractory Carcinoma of the Prostate Metastatic to Bone
15. American Urological Association: Prostate-Specific Antigen (PSA) Best Practice Policy

See: Clinical Practice Guidelines < > Urology < > Oncology >> Prostate Cancer

1. Screening for Testicular Cancer, 1996
   
2. Scottish Intercollegiate Guidelines Network (SIGN): Management of adult testicular germ cell tumours 518 KB, 52 pages
   
3. The management of testicular cancer in Victoria, 1988-1993. MJA 2001; 174: 328-331
   
4. Testicular cancer management MJA 2001; 174: 320-321
5. Screening for Testicular Cancer, 1994
6. Canadian Task Force on the Periodic Health Examination: Screening for Testicular Cancer, 1999

See: Clinical Practice Guidelines < > Urology < > Oncology >> Testicular Tumours

1. Screening for Bladder Cancer
   
2. American Urological Association: Management of non-muscle-invasive bladder cancer, 1999

1. American Association of Endocrinologists (AACE) and American College of Endocrinology (ACE): Thyreoid Carcinoma 288 KB, 19 pages
   
2. American Association of Clinical Endocrinologists and The American College of Endocrinology: Clinical Practice Guidelines for the Diagnosis and Management of Thyroid Nodules
3. Society of Nuclear Medicine: Procedure guideline for extended scintigraphy for differentiated thyroid cancer, 1999
4. Screening for thyroid disorders and thyroid cancer in asymptomatic adults 1994-1999
5. American Thyroid Association: Treatment Guidelines for Patients With Thyroid Nodules and Well-Differentiated Thyroid Cancer, 1996

See: Clinical Practice Guidelines < > Endocrinology < > Oncology >> Thyreoid Carcinoma

1. ICSI: Colorectal cancer screening, Algorithm, 2000 222 k, 25 pages
   
2. Screening for Colorectal Cancer, 1996
   
3. Screening for Colorectal Cancer -- United States, 1992-1993, and New Guidelines. MMWR 1996;45(05);107-110
   
4. Guidelines for the prevention, early detection and management of colorectal cancer: A guide for general practitioners
   
5. Guidelines for the prevention, early detection and management of colorectal cancer: A guide for patients, their families and friends
   
6. Colon and Rectal Cancer Treatment Guidelines for Patients 942 KB, 64 pages
   
7. Guidelines for the prevention, early detection and management of colorectal cancer
   
8. Scottish Intercollegiate Guidelines Network (SIGN): Colorectal cancer, 1997 233 KB, 72 pages
   
9. Full guidance on laparoscopic surgery for colorectal cancer, 2000 56 K, 12 pages
   
10. Guidance on the use laparoscopic surgery for the treatment of colorectal cancer - Patient Information
    
11. HTA report on laparoscopic surgery for colorectal cancer 305 K, 103 pages
    
12. The College of Physicians and Surgeons of Manitoba: Early Detection of Colorectal Cancer
    
13. Referral Guidelines for Suspected Lower Gastrointestinal Cancers
    
14. Follow-up of Patients after Curative Resection of Colorectal Cancer
    
15. Cancer Care Ontario Practice Guidelines Initiative: Chemotherapy After Complete Removal by Surgery of Stage III Colon Cancer
16. Recommended Colorectal Cancer Surveillance Guidelines by the American Society of Clinical Oncology, 1999
17. 2000 Update of American Society of Clinical Oncology Colorectal Cancer Surveillance Guidelines
18. A Structured Approach to Colorectal Biopsy Assessment[1997]
    
19. Australian general practitioners' views and use of colorectal cancer screening tests. MJA 1999; 170: 110-113
    
20. Polyp Guideline: Diagnosis, Treatment, and Surveillance for Patients With Colorectal Polyps
    
21. Cancer Care Ontario Practice Guidelines Initiative: Use of raltitrexed (Tomudex) in the management of metastatic colorectal cancer (Brief Summary)
22. Cancer Care Ontario Practice Guidelines Initiative: Use of Irinotecan in the Treatment of Metastatic Colorectal Carcinoma, 2000

See: Clinical Practice Guidelines < > Gastroenterology < > Oncology >> Colorectal Carcinoma

1. Canadian Task Force on Preventive Health Care: Prevention of pancreatic cancer
2. Screening for Pancreatic Cancer, 1996
   
3. NICE: Guidance on the use of gemcitabine for pancreatic cancer, 2001 106 K, 14 pages
   
4. NICE: Health Technology Assessment Report – Gemcitabine for the treatment of pancreatic cancer, 2001 430 K, 107 pages
   
5. Cancer Care Ontario Practice Guidelines Initiative: Use of Gemcitabine in the Treatment of Advanced Pancreatic Adenocarcinoma, 2000
6. Guidance on the use of gemcitabine for pancreatic cancer - patient leaflet
   

1. Screening for Lung Cancer, 1996
   
2. Scottish Intercollegiate Guidelines Network (SIGN): Management of Lung Cancer, 1998 743 KB, 66 pages
   
3. Guidelines on the selection of patients with lung cancer for surgery. British Thoracic Society and Society of Cardiothoracic Surgeons of Great Britain and Ireland Working Party. Thorax 2001;56:89-108 343 KB, 20 pages
   
4. Guidelines on Diagnostic Flexible Bronchoscopy. British Thoracic Society. Thorax 2001. Vol 56; Supplement I. 256 KB, 21 pages
   
5. NICE: Guidance on the use of docetaxel, paclitaxel, gemcitabine and vinorelbine for the treatment of non-small cell lung cancer 115 K, 16 pages
   
6. NICE: Information for patients on the use of docetaxel, paclitaxel, gemcitabine and vinorelbine for non-small cell lung cancer (Patient information)
   
7. NICE: Health Technology Assessment Report – The use of docetaxel, paclitaxel, gemcitabine and vinorelbine for the treatment of non-small cell lung cancer 853 K, 182 pages
   
8. Cancer Care Ontario Practice Guidelines Initiative: Use of Gemcitabine in Non-Small-Cell Lung Cancer,2000
9. BTS Recommendation to Respiratory Physicians for Organising the Care of Patients with Diffuse Parenchmal Lung Disease (DPLD): Supplement to June issue of Thorax 1998; 53:1. 309 KB, 30 pages
   
10. Cancer Care Ontario Practice Guidelines Initiative: Postoperative Adjuvant Chemotherapy and/or Radiation Therapy in Stage II or IIIA Completely Resected Non-Small Cell Lung Cancer, 2001
11. American College of Radiology: Appropriateness Criteria™ for work-up of the solitary pulmonary nodule (SPN)
12. Cancer Care Ontario Practice Guidelines Initiative: Unresected Stage III Non-Small Cell Lung Cancer, 2000
13. American Society of Clinical Oncology (ASCO): Clinical Practice Guidelines for the Treatment of Unresectable Non-Small-Cell Lung Cancer, 1997
14. Cancer Care Ontario Practice Guidelines Initiative: Use of Vinorelbine in Non-Small Cell Lung Cancer, 2000

1. Royal Devon and Exeter Healthcare NHS Trust - Pigmented Lesions
   
2. Royal Devon and Exeter Healthcare NHS Trust - Moles and Malignant Melanoma (Patient Information)
   
3. Management of Cutaneous Melanoma
   
4. National Institutes of Health Consensus Development Conference Statement. Diagnosis and Treatment of Early Melanoma (originally published as: NIH Consens Statement 1992 Jan 27-29;10(1):1-26)
   
5. Notice to Readers National Melanoma/Skin Cancer Detection and Prevention Month -- May 1998, MMWR 47(16);343
   
6. Survey of Knowledge of and Awareness About Melanoma -- United States, 1995, MMWR 45(17);346-349
   
7. Cancer Care Ontario Practice Guidelines Initiative: Systemic Adjuvant Therapy for Patients at High Risk for Recurrent Melanoma, 2000
8. American Academy of Dermatology: Guidelines of care for primary cutaneous melanoma

1. Society of Nuclear Medicine: Procedure guideline for tumor imaging using F-18 FDG, 1999 29 K, 11 pages.
2. American College of Radiology Appropriateness Criteria™ for follow-up and retreatment of brain metastases, 2000 108 K, 8 pages.
3. American College of Radiology Appropriateness Criteria™ for solitary brain metastasis 114 K, 10 pages.
4. American College of Radiology Appropriateness Criteria™ for multiple brain metastases, 2000 109 K, 8 pages.
   
5. Official American Academy of Neurology Practice Statements: Evaluation and management of intracranial mass lesions in AIDS, 1998 981 K, 6 pages.
6. ACR Appropriateness Criteria™ for pre-irradiation evaluation and management of brain metastasis, 2000 103 K, 6 pages.

   ---

   Skin Cancer

   1. Canadian Task Force on Preventive Health Care: Prevention of Skin Cancer, 1994
   2. Screening for skin cancer: recommendations and rationale, 2001
   3. American College of Preventive Medicine: Skin Protection from Ultraviolet Light Exposure, 1998

   ---

   Head and Neck Cancer

   1. Canadian Task Force on Preventive Health Care: Prevention of Oral Cancer, 1994
      
   2. Preventive Health Care, 1999 Update: Prevention of Oral Cancer Mortality
   3. Cancer Care Ontario Practice Guidelines Initiative: Symptomatic Treatment of Radiation-Induced Xerostomia in Head and Neck Cancer Patients, 2000

   ---

   Bone Tumors

   1. ACR Appropriateness Criteria™ for bone tumors, 1995-1999 94 K, 4 pages.

   ---

   Uterine Tumors

   1. New Zealand Guidelines Group: Guidelines for the Management of Uterine Fibroids (Word document, 549 K, 118 pages)

   ---

   Cancer Pain

   1. American Society of Anesthesiologists: Practice Guidelines for Cancer Pain Management, Anesthesiology 1996;84:1243-57
      
   2. AHCPR Clinical Practice Guideline: Management of Cancer Pain
      
   3. Cancer Pain Treatment Guidelines for Patients 538 KB, 79 pages
      

   ---

   General

   1. Cancer Care Ontario Practice Guidelines Initiative (CCOPGI) Clinical Practice Guidelines and Evidence Summaries
      
   2. Neoplastic Diseases
      
   3. CancerNet - Cancer Information Summaries
      
   4. American Society of Clinical Oncology Clinical Practice Guidelines
      
   5. Familial aspects of cancer: a guide to clinical practice
      
   6. Preventive Interventions in Primary Health Care - Cardiovascular Disease and Cancer
      

   ---

   Disclaimer: The recommendations are systematically developed statements to assist practitioner and patient decisions about appropriate health care for specific clinical circumstances. They should be used as an adjunct to sound clinical decision making. The information provided on the BHP Clinical Practice Guidelines Home Page is for information only, and is not a substitute for talking to a health professional. The views or opinions stated in external resources which are links on this home page do not necessarily reflect those of the BHP Clinical Practice Guidelines.